This is why its effects are so widespread, from improving skins appearance to supporting wound healing
Verdict at a Glance Both Dihexa and PE-22-28 are preclinical nootropic peptides with no human data, making any clinical recommendation premature
drugs under pre-clinical or clinical development or discontinued, designer drugs, substances approved only for veterinary use) is prohibited at all times. So, to summarize: BPC-157 may be beneficial in healing orthopedic injuries, but it is not approved for FDA usage and therefore banned under the WADA Code
Neither is approved for human use by the FDA or any other major regulatory body, and the findings below come from laboratory and animal studies
Common side effects are mild and may include temporary injection-site irritation, headache, transient flushing, and slight appetite changes